DK32786A - Anvendelse af dipeptidderivater til fremstilling af laegemidler til behandling af posttraumatiske nerveskader - Google Patents

Anvendelse af dipeptidderivater til fremstilling af laegemidler til behandling af posttraumatiske nerveskader Download PDF

Info

Publication number
DK32786A
DK32786A DK32786A DK32786A DK32786A DK 32786 A DK32786 A DK 32786A DK 32786 A DK32786 A DK 32786A DK 32786 A DK32786 A DK 32786A DK 32786 A DK32786 A DK 32786A
Authority
DK
Denmark
Prior art keywords
treatment
stands
hydrogen atom
dipeptide derivatives
posttraumatic
Prior art date
Application number
DK32786A
Other languages
English (en)
Other versions
DK165733C (da
DK165733B (da
DK32786D0 (da
Inventor
Hubert Giertz
Hans Barth
Leopold Flohe
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of DK32786D0 publication Critical patent/DK32786D0/da
Publication of DK32786A publication Critical patent/DK32786A/da
Publication of DK165733B publication Critical patent/DK165733B/da
Application granted granted Critical
Publication of DK165733C publication Critical patent/DK165733C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/066—TRH, thyroliberin, thyrotropin releasing hormone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK032786A 1985-01-23 1986-01-22 Anvendelse af dipeptiderivater til fremstilling a f laegemidler til forhindring eller behandling af posttraumatiske nerveskader efter ved uheld fremkaldte rygmarvs- og/eller hjernetraumer. DK165733C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3502041 1985-01-23
DE19853502041 DE3502041A1 (de) 1985-01-23 1985-01-23 Verwendung von dipeptidderivaten zur behandlung posttraumatischer nervenschaeden

Publications (4)

Publication Number Publication Date
DK32786D0 DK32786D0 (da) 1986-01-22
DK32786A true DK32786A (da) 1986-07-24
DK165733B DK165733B (da) 1993-01-11
DK165733C DK165733C (da) 1993-06-07

Family

ID=6260477

Family Applications (1)

Application Number Title Priority Date Filing Date
DK032786A DK165733C (da) 1985-01-23 1986-01-22 Anvendelse af dipeptiderivater til fremstilling a f laegemidler til forhindring eller behandling af posttraumatiske nerveskader efter ved uheld fremkaldte rygmarvs- og/eller hjernetraumer.

Country Status (11)

Country Link
US (1) US4906614A (da)
EP (1) EP0188810B1 (da)
JP (1) JPS61172828A (da)
AT (1) ATE57834T1 (da)
AU (1) AU578999B2 (da)
DE (2) DE3502041A1 (da)
DK (1) DK165733C (da)
IE (1) IE58805B1 (da)
IL (1) IL77218A (da)
SG (1) SG83791G (da)
ZA (1) ZA859187B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2219501B (en) * 1987-04-08 1990-09-26 Nippon Shinyaku Co Ltd Nootropic agent.
US5686420A (en) * 1987-06-05 1997-11-11 Georgetown University Thyrotropin-releasing hormone analogs and method of use
JPS63316724A (ja) * 1987-06-19 1988-12-26 Nippon Shinyaku Co Ltd 抗けいれん剤
US5049553A (en) * 1990-01-04 1991-09-17 E. R. Squibb & Sons, Inc. Method for preventing or treating symptoms resulting from closed head injuries employing an ace inhibitor
US6812208B2 (en) 1993-12-23 2004-11-02 Neuronz Ltd. Methods to improve neural outcome
CA2178711A1 (en) * 1993-12-23 1995-06-29 Peter David Gluckman Composition and methods to improve neural outcome
US5897858A (en) 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US6187906B1 (en) * 1997-08-11 2001-02-13 Aukland Uniservices Limited Methods to improve neural outcome
US20020151502A1 (en) * 1997-10-09 2002-10-17 Albert Sattin Tri-peptides for neurological and neurobehavior applications
US6475989B1 (en) 1997-10-09 2002-11-05 Albert Sattin Use of pyroglutamyl-glutamyl-prolyl amide (EEP) for neurological and neurobehavioral disorders
US20050233973A1 (en) * 1997-10-09 2005-10-20 Albert Sattin Tri-peptides for antidepressant applications
WO2001028578A2 (en) * 1999-10-22 2001-04-26 Wrair A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME
US6815425B1 (en) 1999-10-22 2004-11-09 The United States Of America As Represented By The Secretary Of The Army Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases and injuries to the brain, spinal cord and retina using same
IE20000240A1 (en) * 2000-02-17 2003-03-05 Trinity College Dublin TRH-like peptide derivatives
US7112570B2 (en) * 2000-08-24 2006-09-26 Neuren Pharmaceuticals, Ltd. GPE analogs
WO2002016408A2 (en) * 2000-08-24 2002-02-28 Neuronz Ltd. Gpe analogs
US7605177B2 (en) * 2001-05-24 2009-10-20 Neuren Pharmaceuticals Limited Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
US7714020B2 (en) * 2001-05-24 2010-05-11 Neuren Pharmaceuticals Limited Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
US20070004641A1 (en) * 2001-05-24 2007-01-04 Neuren Pharmaceuticals Limited Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamate
ATE435852T1 (de) 2001-05-24 2009-07-15 Neuren Pharmaceuticals Ltd Gpe-analoga und peptidomimetika
US8791117B2 (en) 2003-09-03 2014-07-29 Neuren Pharmaceuticals Limited Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue
EP1794182B1 (en) * 2004-10-01 2015-06-03 The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin Compounds that modulate trh actions and inhibit the trh-degrading enzyme
JP6574769B2 (ja) 2013-07-25 2019-09-11 ニューレン ファーマシューティカルズ リミテッド 二環式化合物ならびに自閉症スペクトラム障害および神経発達障害の治療におけるそれらの使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449167C2 (de) 1974-10-16 1984-05-24 Grünenthal GmbH, 5190 Stolberg N-Acyl-L-histidyl-L-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE2615455C2 (de) * 1976-04-09 1985-06-20 Grünenthal GmbH, 5190 Stolberg N-Acyl-L-histidyl-L-prolin (N-substituierte)-amide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions

Also Published As

Publication number Publication date
IE852905L (en) 1986-07-23
US4906614A (en) 1990-03-06
DE3580351D1 (de) 1990-12-06
IL77218A (en) 1990-11-05
ZA859187B (en) 1986-08-27
DK165733C (da) 1993-06-07
DE3502041A1 (de) 1986-07-24
ATE57834T1 (de) 1990-11-15
JPH0584286B2 (da) 1993-12-01
DK165733B (da) 1993-01-11
IE58805B1 (en) 1993-11-17
SG83791G (en) 1991-11-22
AU5260186A (en) 1986-07-31
JPS61172828A (ja) 1986-08-04
EP0188810B1 (de) 1990-10-31
DK32786D0 (da) 1986-01-22
AU578999B2 (en) 1988-11-10
EP0188810A2 (de) 1986-07-30
EP0188810A3 (en) 1988-09-07

Similar Documents

Publication Publication Date Title
DK32786A (da) Anvendelse af dipeptidderivater til fremstilling af laegemidler til behandling af posttraumatiske nerveskader
DE3164764D1 (en) 1,1,2-triphenyl-but-1-ene derivatives, process for their manufacture and their use as pharmaceutical agents
MY100343A (en) Amide derivative and external medicament comprising same
AU8169287A (en) New diphosphonic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DK0421561T3 (da) 24-homo-vitamin-D-derivater, fremgangsmåder til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemiddel
IL111581A (en) Cyclic amino acid derivatives pharmaceutical compositions containing them and process for their preparation
ES2039196T3 (es) Procedimiento para preparar 4-(1,2,5,6-tetrahidro-1-alquil-3-piridinil)-2-tiazolaminas y 4-(hexahidro-1-alquil-3-piridinil)-2-tiazolaminas.
DE58904337D1 (de) Arzneimittel enthaltend nitroxyalkylamine mit amidfunktion und verfahren zur herstellung dieser verbindungen.
ES2109216T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica con actividad relajante muscular de accion central.
HK1000284A1 (en) N-(5,6,7,8-tetrahydropyrido(2,3D)pyrimidin-6-Yl-alkanoyl)-glutamic acid derivatives
DE3775496D1 (de) Benzhydryloxyaethyl-piperidine-derivate, verfahren zur herstellung und pharmazeutische zusammenstellungen, die diese enthalten.
EP0228314A3 (en) Use of ethanol/amine derivatives in treating or preventing hyperlipemia
ES557149A0 (es) Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida.
ES487631A1 (es) Procedimiento para la obtencion de hexahidro-1,4-oxazepinas
EP0334674A3 (en) Use of isoxazolinones as cerebro-active drugs
IE863088L (en) Peptide immunostimulants
ES2027492A6 (es) Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables.
EP0220654A3 (en) Gonadoliberine analogues, process for preparing them, pharmaceutical composition and use
ES2058315T3 (es) Compuestos eficaces contra insuficiencia cerebral.
GB1313838A (en) 3,4,5-trialkoxybenzoic acid derivatives and their uses
ES8704477A1 (es) Procedimiento para preparar piridin-1-oxidos varias veces substituidos
TH1819B (th) การเตรียมอนุพันธ์ 1-แอลคิล-2-อะมิโน-เททราลิน
ES477164A1 (es) Un procedimiento de preparacion de 6-ciclopropil-1,3-dihi- dro-5-fenil-2-oxo-2h-tieno (2,3-e) diazepina.
LTIP1787A (en) Novel acrylic amide derivatives, aprocess for their preparation, pharmaceutical compositions containing the same and their use in medicine
FR2633292B1 (fr) Nouveaux derives de la 20,21-dinoreburnamenine substitues en 15 par un groupement amine, leur procede de preparation et les intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les reenfermant

Legal Events

Date Code Title Description
PBP Patent lapsed